RETRACTED: SARS-CoV2 mRNA vaccine intravenous administration induces myocarditis in chronic inflammation
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0311726 ↗Kurz gefasst
Zurückgezogene Publikation in der Zeitschrift PLOS ONE, 2024. Verfasst von Ha-Eun Jeon und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science, Jungwon University, Goesan-gun, Chungbuk, Republic of Korea. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, mRNA Vaccines, Myocarditis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Food and Drug Safety Evaluation, Korea Health Industry Development Institute.
Abstract (Originalsprache)
The current COVID-19 mRNA vaccines were developed and applied for pandemic-emergent conditions. These vaccines use a small piece of the virus’s genetic material (mRNA) to stimulate an immune response against COVID-19. However, their potential effects on individuals with chronic inflammatory conditions and vaccination routes remain questionable. Therefore, we investigated the effects of mRNA vaccines in a mouse model of chronic inflammation, focusing on their cardiac toxicity and immunogenicity dependent on the injection route. mRNA vaccine intravenous administration with or without chronic inflammation exacerbated cardiac pericarditis and myocarditis; immunization induced mild inflammation and inflammatory cytokine IL-1beta and IL-6 production in the heart. Further, IV mRNA vaccination induced cardiac damage in LPS chronic inflammation, particularly serum troponin I (TnI), which dramatically increased. IV vaccine administration may induce more cardiotoxicity in chronic inflammation. These findings highlight the need for further research to understand the underlying mechanisms of mRNA vaccines with chronic inflammatory conditions dependent on injection routes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Science, Jungwon University, Goesan-gun, Chungbuk, Republic of Korea.
- Department of Medical and Biological Sciences, The Catholic University of Korea, Gyeonggi-do, Bucheon, Republic of Korea.
- Department of Biotechnology, The Catholic University of Korea, Gyeonggi-do, Bucheon, Republic of Korea.
- Division of Cardiology, Samsung Medical Center, 50 Irwon Dong, Gangnam-gu, Seoul, Republic of Korea.
- SML Biopharm, Gyeonggi-do, Gwangmyeong, Republic of Korea.
ORCID-Profile: Seonghyun Lee, Byung-Kwan Lim
Förderung
- National Institute of Food and Drug Safety Evaluation
- Korea Health Industry Development Institute
Zitieren
APA
Jeon, H. E., Lee, S., Lee, J., Roh, G., Park, H. J., Lee, Y. S., Kim, Y. J., Kim, H. K., Shin, J. H., Lee, Y. J., Gil, C. O., Jeon, E. S., Nam, J. H., & Lim, B. K. (2024). RETRACTED: SARS-CoV2 mRNA vaccine intravenous administration induces myocarditis in chronic inflammation. PLOS ONE. https://doi.org/10.1371/journal.pone.0311726
Vancouver
Jeon HE, Lee S, Lee J, Roh G, Park HJ, Lee YS, et al. RETRACTED: SARS-CoV2 mRNA vaccine intravenous administration induces myocarditis in chronic inflammation. PLOS ONE. 2024. doi:10.1371/journal.pone.0311726
BibTeX
@article{Jeon2024,
author = {Jeon, Ha-Eun and Lee, Seonghyun and Lee, Jisun and Roh, Gahyun and Park, Hyo-Jung and Lee, Yu-Sun and Kim, Yeon-Jung and Kim, Hong-Ki and Shin, Ji-Hwa and Lee, You-Jeung and Gil, Chae-Ok and Jeon, Eun-Seok and Nam, Jae-Hwan and Lim, Byung-Kwan},
title = {RETRACTED: SARS-CoV2 mRNA vaccine intravenous administration induces myocarditis in chronic inflammation},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0311726}
}
EUVIMED